Value of core needle biopsy in histopathological and immunohistochemical assessment of liver tumors

https://doi.org/10.53730/ijhs.v6nS2.8491

Authors

  • Zainab Mohammed Jawad Kadhim M.B.Ch.B. Arab Council for health specialization. Al –Sadr teaching hospital, Al-Najaf, Iraq
  • Asaad Abdul hamza Al-Janabi PhD histopathology. Department of Pathology, collage of medicine ,university of kufa, Al –Sadr teaching hospital, Al-Najaf, Iraq

Keywords:

liver tumors, core needle biopsy, hepatocellular carcinoma

Abstract

Introduction: Liver is the most commonly involved organ by metastatic disease. Secondary tumors are more frequent lesion forming more than 75%, while primary cancers of liver formed less than 25%. Imaging according to LI-RAD can give a clue for the nature of the primary lesion of live particularly hepatocellular carcinoma.  Liver biopsy is still the golden standard surveillance for histopathological diagnosis of liver tumor; however, it is a traumatic procedure, but its value in reaching the definite diagnosis is superior to imaging technique. Tru cut biopsy is less traumatic than open biopsy and considered nowadays as the preferable technical way in sampling liver tissue that can be applied for both histopathology and immunohistochemistry. Secondary liver lesions were encountered to be originated from lung, breast, Pancreatobiliary tract and GIT, female genital tract, prostate and others.  Objectives of the Study: To assess the efficacy of Tru cut biopsy for both histopathological examination and immunohistochemical study identification the type and origin of liver tumors. Methodology: This is a cross sectional study conducted in the Al-Sadr Teaching Hospital in Al-Najaf City, Iraq from January 2019 till December 2021. 

Downloads

Download data is not yet available.

References

Ridder J, Wilt J, Simmer F, Overbeek L, Lemmens V, Nagtegaal I. Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients. Oncotarget. 2016;7(34):55368-55376.

Hugen N, Velde C, Wilt J, Nagtegaal I. Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Annals of Oncology. 2014;25(3):651-657.

Liu Q, Zhang H, Jiang X, Qian C, Liu Z, Lou D. Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis. Molecular Cancer. 2017;16:176.

Costa-Silva B, Aiello N, Ocean A et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology. 2015;17(6):816-826.

Eveno C, Hainaud P, Rampanou A et al. Proof of prometastatic niche induction by hepatic stellate cells. Journal of Surgical Research. 2015;194(2):496-504.

Herbst D. Reddy K. Risk factors for hepatocellular carcinoma. Clinical Liver Disease. 2012;1(6):180-182.

Yang J, Hainaut P, Gores G, Amadou A, Plymoth A, Roberts L. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature Reviews, Gastroenterology & Hepatology. 2019;16(10):589-604.

Janevska D, Chaloska-Ivanova V, Janevski V. Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment. Open Access Macedonian Journal Of Medical Sciences. 2015;3(4):732-736.

Cevik F, Aykin N, Naz H. Complications and efficiency of liver biopsies using the Tru-Cut biopsy Gun. Journal of Infection in Developing Countries. 2010;4(2):91-95.

Adali Y, Eroglu H, Makav M, Karayol S, Guvendi G, Gok M. Comparison of tru-cut biopsy and fine-needle aspiration cytology in an experimental alcoholic liver disease model. Revista da Associacao Medica Brasileira. 2020;66(8):1030-1035.

Stift J, Semmler G, Woran K et al. Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy. Liver, Pancreas, and Biliary Tract. 2020;52(12):1473-1479.

Sherman K, Goodman Z, Sullivan S et al. Liver biopsy in cirrhotic patients. American Journal of Gastroenterology. 2007;102(4):789-793.

Lo R, Ng I. Hepatocellular Tumors: Immunohistochemical Analyses for Classification and Prognostication. Chinese Journal of Cancer Research. 2011;23(4):245-253.

Lopez G, Boggio F, Ferrero S, Fusco N, Gobbo A. Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma. International Journal of Molecular Sciences. 2018;19(10):3014.

Takahashi Y, Dungubat E, Kusano H et al. Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors. International Journal of Molecular Sciences. 2021;22(11):5780.

Gonzalez A, Salomao M, Lagana S. Current concepts in the immunohistochemical evaluation of liver tumors. World Journal of Hepatology. 2015;7(10):1403-1411.

Fanni D, Gerosa C, Faa G. The Histomorphological and Immunohistochemical Diagnosis of Hepatocellular Carcinoma. In: Wan-Yee Lau J, ed. Hepatocellular Carcinoma - Clinical Research. London: IntechOpen; 2012;4:65-88.

Golubnitschaja O, Sridhar K. Liver metastatic disease: new concepts and biomarker panelsto improve individual outcomes. Clinical & Experimental Metastasis. 2016;33:743-755.

Selves J, Long-Mira E, Mathieu M, Rochaix P, Lile M. Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site. Cancers. 2018;10(4):108.

National Institute for Health and Care Excellence. Chapter 2: Diagnosis, in Diagnosis and management of metastatic malignant disease of unknown primary origin. Cardiff (UK): National Collaborating Centre for Cancer (UK). 2010;2:21-32.

The manual of surgical pathologists. Third edition ,Chapter 19:gastrointestinal specimen including hepatobiliary and pancreatic specimen

ancroft's theory and practice of histopathological techniques. Eighth edition ,appendix III Applications of immunohistochemistry .

Wang ZG, He ZY, Chen YY, Gao H, Du XL. Incidence and survival outcomes of secondary liver cancer: a Surveillance Epidemiology and End Results database analysis. Transl Cancer Res 2021;10(3):1273-1283. doi: 10.21037/tcr-20-3319

Altaee W. Hepatocellular Carcinoma Presentation & Management, A Prospective Study in the Medical City Baghdad - Iraq. The Iraqi Postgraduate Medical Journal. 2011;10(2):253-259

Zhang W, Sun B. Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the SEER database. Oncotarget. 2015;6(2):633-641

Hefaiedh R, Ennaifer R, Romdhane H et al. Gender difference in patients with hepatocellular carcinoma. La Tunisie Medicale. 2013;91(8-9):505-508

riscom JT, Wolf PS. Liver Metastasis. [Updated 2021 Apr 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553118/

Horn SR, Stoltzfus KC, Lehrer EJ, Dawson LA, Tchelebi L, Gusani NJ, Sharma NK, Chen H, Trifiletti DM, Zaorsky NG. Epidemiology of liver metastases. Cancer Epidemiol. 2020 Aug;67:101760. doi: 10.1016/j.canep.2020.101760. Epub 2020 Jun 17. PMID: 32562887.

Altajer, A., Efendi, S., Jabbar, A., Oudah Mezan, S., Thangavelu, L., M. Kadhim, M., F. Alkai, A. (2021). Novel Carbon Quantum Dots: Green and Facile Synthesis, Characterization and its Application in On-off-on Fluorescent Probes for Ascorbic Acid. Journal of Nanostructures, 11(2), 236-242. doi: 10.22052/JNS.2021.02.004

Neuberger J, Patel J, Caldwell H, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 2020;69(8):1382-1403.

Published

06-06-2022

How to Cite

Kadhim, Z. M. J., & Al-Janabi, A. A. hamza. (2022). Value of core needle biopsy in histopathological and immunohistochemical assessment of liver tumors. International Journal of Health Sciences, 6(S2), 13191–13199. https://doi.org/10.53730/ijhs.v6nS2.8491

Issue

Section

Peer Review Articles